Several recent developments point to Kigali’s growing role in Africa’s biopharmaceutical landscape. Rwanda has positioned itself as a strategic hub through a combination of investment in scientific ...

BioNTech’s facility should bolster Germany’s capabilities as a hub for medical innovation and strengthen Europe’s medical supply chain, he said. The €40 million ($44 million) project at the company’s ...

German Chancellor Olaf Scholz is visiting the new manufacturing facility in Marburg today together with BioNTech co-founders Prof. Ugur Sahin, M.D., Chief Executive Officer, and Prof. Özlem ...

German Chancellor Olaf Scholz is visiting the new manufacturing facility in Marburg today together with BioNTech co-founders Prof. Ugur Sahin, M.D., Chief Executive Officer, and Prof. Özlem ...